title: Immune therapy for ovarian cancer: promise and pitfalls.
abstract: This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.
authors.affiliation: Department of Medicine, School of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA.
authors.forename: Suzanne R
authors.initials: SR
authors.lastname: Thibodeaux
authors.forename: Tyler J
authors.initials: TJ
authors.lastname: Curiel
mesh_terms: D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000276:immunology / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000276:immunology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D016207:Cytokines